Skip to main content
Contact Us
Subscribe
E-Edition
76°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CNS Pharmaceuticals, Inc. - Common Stock
(NQ:
CNSP
)
1.280
+0.020 (+1.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CNS Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Gold Moves Lower; AT&T Earnings Top Views
October 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 23, 2024
Via
Benzinga
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 23, 2024
Via
ACCESSWIRE
Why CNS Pharmaceuticals (CNSP) Stock Is Up 86%
October 23, 2024
CNS Pharmaceuticals shares are trading higher by 76% Wednesday morning. The stock faces potential delisting for not meeting Nasdaq's $1.00 bid price.
Via
Benzinga
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
October 23, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
October 10, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
October 08, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
September 23, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 23, 2024
Via
Benzinga
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
October 23, 2024
Via
Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Management, Dr. Samuel Goldlust Participate in Virtual Investor KOL Connect Segment
October 10, 2024
Via
Investor Brand Network
Jimmy Carter Survival Thanks to Novel Cancer Immunotherapy Treatment
October 04, 2024
Via
Investor Brand Network
CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
August 27, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
August 22, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 15, 2024
Via
ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum
September 23, 2024
Via
Investor Brand Network
WHO Review Says No Link Between Mobile Phones, Brain-Cancer Development
September 13, 2024
Via
Investor Brand Network
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
September 12, 2024
Via
ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
Via
Investor Brand Network
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
Via
ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode
September 03, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
August 27, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Upcoming Virtual Investor CEO Connect Segment
August 22, 2024
Via
Investor Brand Network
Scientists Find Way to Boost Natural Killer Cells Targeting Pediatric Brain Cancer
August 21, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results
August 15, 2024
Via
Investor Brand Network
Exposures
Product Safety
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q2 2024
August 15, 2024
CNS Pharmaceuticals just reported results for the second quarter of 2024.
Via
InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
August 06, 2024
Via
Benzinga
Study Uncovers How Brain Tumors Evolve During Treatment
August 05, 2024
Via
Investor Brand Network
Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
August 05, 2024
Via
Benzinga
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
